MILGAMMA mono 150 coated tablets, 100 pcs

Instructions for use for MILGAMMA mono 150 coated tablets, 100 pcs

Detailed instructions for MILGAMMA mono 150 coated tablets, 100 pcs

Field of use

milgamma® Mono 150 contains vitamin B1 for the nerve cells. The unique active ingredient Benfotiamine, a variant of the vitamin B1, is absorbed 5 times better by the body than conventional vitamin B1. For the treatment and prophylaxis of vitamin B1 deficiency states.
Milgamma® Mono 50 is well tolerated, lactose and Gulten-free.

Active ingredients / ingredients / ingredients

150 mg benfotiamine
Arab rubber auxiliary substance (+)
Calcium carbonate auxiliary material (+)
Cellulose, microcrystalline auxiliary material (+)
Crooscarmellosis, sodium salt auxiliary material (+)
Glycerol 85% auxiliary material (+)
Macrogol 6000 Hedge Terms (+)
Corn starch auxiliary substance (+)
Montannglycol wax auxiliary material (+)
Partial glyceride, long -chain auxiliary material (+)
Polysorbate 80 HILDVERSTOFT (+)
Povidon K30 auxiliary material (+)
Saccharosis auxiliary substance (+)
Schellack auxiliary substance (+)
Silicium dioxide, high disperser auxiliary substance (+)
Talcum auxiliary material (+)
Titan dioxide HILDBOFT (+)

Contradictions

milgamma® Mono 150 must not be taken if you are allergic to the active ingredient Benfotiamine or against Thiamin or one of the other components of this medicine mentioned in section 6 of the use information.

dosage

- 1 Dragee every day
- In rare cases, more.

For the therapy of neuropathies, Milgamma® Mono 150 should initially be taken over a period of at least 3 weeks. Then further treatment according to the therapeutic success.

Taking

- The dragees are taken with some liquid.

Patient information

- The duration of the intake depends on the success of the treatment.

Pregnancy

During pregnancy and breastfeeding, you should only take medication after consultation with your doctor or pharmacist!

- The recommended vitamin B1 intake during pregnancy and breastfeeding is 1.4-2.3 mg.
- Vitamin B1 is excreted in breast milk.
- The drug should only be taken during pregnancy and lactation if a significant defect has been proven. The drug may only be used at short notice, since there is no experience with overdoses during pregnancy and breastfeeding.

Hints

milgamma® Mono 150. Active ingredient: Benfotiamin 150 mg. Areas of application: Therapy or prophylaxis of clinical vitamin B1 deficiency states, provided that they cannot be remedied; Treatment of neuropathies and cardiovascula. Sturgeon., D. Through vitamin B1-MAngel are caused. Read the package supplement and ask your doctor or pharmacist for risks and side effects. Wörwag Pharma GmbH & Co. KG, 71034 Böblingen

Miscellaneous

The B1 deficiency can occur at:
- Lack of deficiency and malnutrition (e.g. Beriberi)
- Zero diet
- Chronic alcoholism
- Increased need (e.g. pregnancy and breastfeeding)

Vitamin B1 deficiency symptoms:
- The complaints of the fully pronounced vitamin B1 deficiency (Beriberi) are nerve disorders with sensitivity disorders, muscle weakness, coordination disorders, paralysis as well as mental disorders, gastrointestinal disorders and disorders of the heart and vessels.

Manufacturer:  Wörwag Pharma GmbH & Co. KG, Calwer Straße 7, 71034 Böblingen